Skip to content
Disclosery

Endurant Capital Management LP

Follow

13F filer, CIK 1633055, San Mateo, CA

Endurant Capital Management LP reported $307,049,000 across 49 holdings for the quarter ended 2022-09-30, in a 13F-HR filed 2022-11-14. Its ten largest share positions make up 56.38% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001633055-22-000007

Period
2022-09-30
Reported value
$307M
Holdings
49
Top 10 weight
56.38%
New
21
Sold out
22

Largest buys vs the previous quarter

SecurityShares changeApprox. value
TAKnew+1,102,280$14.3M
LABORATORY CRP OF AMER HLDGSadded+62,527$12.8M
LLYnew+38,311$12.4M
BMYnew+158,721$11.3M
CATALENT INC USD 0.01new+140,077$10.1M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
BSXexited-418,165-$15.6M
HOLXexited-127,656-$8.85M
AVTRreduced-374,873-$7.35M
SEAGEN INCexited-32,871-$5.82M
CNCexited-68,305-$5.78M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2022

Share positions as resolved from 13F-HR 0001633055-22-000007, largest first. % of portfolio is the value over $307,049,000, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
INVACARE CORPINVACARE CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: 56,727,000 shares; 2022Q3: 56,727,000 shares 56,727,000$49.1M15.98%0
LABORATORY CRP OF AMER HLDGSLABORATORY CRP OF AMER HLDGSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: 34,718 shares; 2022Q3: 97,245 shares 97,245$19.9M6.49%+62,527
HUMHUMANA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: 27,106 shares; 2022Q3: 32,729 shares 32,729$15.9M5.17%+5,623Timeline
TAKTAKEDA PHARMACEUTICAL CO LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: not reported; 2022Q3: 1,102,280 shares 1,102,280$14.3M4.66%newTimeline
BAXBAXTER INTL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: 89,863 shares; 2022Q3: 245,093 shares 245,093$13.2M4.3%+155,230Timeline
QIAGEN NVQIAGEN NVQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: 398,221 shares; 2022Q3: 303,928 shares 303,928$12.5M4.09%-94,293
LLYELI LILLY & COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: not reported; 2022Q3: 38,311 shares 38,311$12.4M4.03%newTimeline
BMRNBIOMARIN PHARMACEUTICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: 25,975 shares; 2022Q3: 145,374 shares 145,374$12.3M4.01%+119,399Timeline
ICLRICON PUB LTD COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: 49,718 shares; 2022Q3: 66,437 shares 66,437$12.2M3.98%+16,719Timeline
BMYBRISTOL-MYERS SQUIBB COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: not reported; 2022Q3: 158,721 shares 158,721$11.3M3.67%newTimeline
CATALENT INC USD 0.01CATALENT INC USD 0.01Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: not reported; 2022Q3: 140,077 shares 140,077$10.1M3.3%new
CITHE CIGNA GROUPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: 40,372 shares; 2022Q3: 34,099 shares 34,099$9.46M3.08%-6,273Timeline
OHIOMEGA HEALTHCARE INVS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: not reported; 2022Q3: 313,762 shares 313,762$9.25M3.01%newTimeline
INVACARE CORPINVACARE CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: 10,097,000 shares; 2022Q3: 10,097,000 shares 10,097,000$8.44M2.75%0
ELUTELUTIA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: 1,133,183 shares; 2022Q3: 1,139,932 shares 1,139,932$8.21M2.67%+6,749Timeline
BDXBECTON DICKINSON & COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: not reported; 2022Q3: 34,282 shares 34,282$7.64M2.49%newTimeline
ELVELEVANCE HEALTH INC FORMERLYQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: not reported; 2022Q3: 16,402 shares 16,402$7.45M2.43%newTimeline
ZTSZOETIS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: 41,100 shares; 2022Q3: 44,286 shares 44,286$6.57M2.14%+3,186Timeline
SELECTA BIOSCIENCES INCSELECTA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: 4,611,635 shares; 2022Q3: 3,938,409 shares 3,938,409$6.46M2.1%-673,226
AZNASTRAZENECA PLC-SPONS ADRQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: not reported; 2022Q3: 101,048 shares 101,048$5.54M1.8%newTimeline
MCKMCKESSON CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: 15,984 shares; 2022Q3: 16,168 shares 16,168$5.5M1.79%+184Timeline
OCULOCULAR THERAPEUTIX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: 760,228 shares; 2022Q3: 1,064,295 shares 1,064,295$4.42M1.44%+304,067Timeline
EHCENCOMPASS HEALTH CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: not reported; 2022Q3: 82,929 shares 82,929$3.75M1.22%newTimeline
THCTENET HEALTHCARE CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: 47,442 shares; 2022Q3: 70,535 shares 70,535$3.64M1.18%+23,093Timeline
VTRVENTAS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: not reported; 2022Q3: 85,683 shares 85,683$3.44M1.12%newTimeline
ALBIREO PHARMA INCALBIREO PHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: 37,835 shares; 2022Q3: 172,621 shares 172,621$3.34M1.09%+134,786
BIOBIO RAD LABS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: 16,028 shares; 2022Q3: 6,984 shares 6,984$2.91M0.95%-9,044Timeline
MMSIMERIT MED SYS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: 20,223 shares; 2022Q3: 51,218 shares 51,218$2.89M0.94%+30,995Timeline
RCUSARCUS BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: 64,756 shares; 2022Q3: 97,327 shares 97,327$2.55M0.83%+32,571Timeline
INSMINSMED INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: 142,071 shares; 2022Q3: 107,713 shares 107,713$2.32M0.76%-34,358Timeline
LKFTLAKEFRONT BIOTHERAPEUTICS NVQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: 51,410 shares; 2022Q3: 50,822 shares 50,822$2.17M0.71%-588Timeline
ADAPYADAPTIMMUNE THERAPEUTICS PLC SQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: 1,824,065 shares; 2022Q3: 1,788,517 shares 1,788,517$1.92M0.63%-35,548Timeline
CANO HEALTH INCCANO HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: not reported; 2022Q3: 210,915 shares 210,915$1.83M0.6%new
VCYTVERACYTE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: not reported; 2022Q3: 108,751 shares 108,751$1.8M0.59%newTimeline
AVTRAVANTOR INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: 450,821 shares; 2022Q3: 75,948 shares 75,948$1.49M0.48%-374,873Timeline
SUTRO BIOPHARMA INCSUTRO BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: 357,465 shares; 2022Q3: 266,679 shares 266,679$1.48M0.48%-90,786
TEVATEVA PHARMACEUTICAL INDS LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: 459,829 shares; 2022Q3: 179,226 shares 179,226$1.45M0.47%-280,603Timeline
OPCHOPTION CARE HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: not reported; 2022Q3: 43,457 shares 43,457$1.37M0.45%newTimeline
ACHACCENDRA HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: not reported; 2022Q3: 55,914 shares 55,914$1.35M0.44%newTimeline
PCVXVAXCYTE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: not reported; 2022Q3: 52,309 shares 52,309$1.25M0.41%newTimeline
REATA PHARMACEUTICALS INCREATA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: not reported; 2022Q3: 24,352 shares 24,352$612K0.2%new
MRVIMARAVAI LIFESCIENCES HLDGS IQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: 23,015 shares; 2022Q3: 22,709 shares 22,709$580K0.19%-306Timeline
ABOSACUMEN PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: not reported; 2022Q3: 55,328 shares 55,328$555K0.18%newTimeline
MIRATI THERAPEUTICS INCMIRATI THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: not reported; 2022Q3: 7,915 shares 7,915$553K0.18%new
RLMDRELMADA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: not reported; 2022Q3: 14,145 shares 14,145$524K0.17%newTimeline
CYTKCYTOKINETICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: 11,538 shares; 2022Q3: 9,211 shares 9,211$446K0.15%-2,327Timeline
MORPHOSYS AGMORPHOSYS AGQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: not reported; 2022Q3: 68,290 shares 68,290$344K0.11%new
BIODESIX INCBIODESIX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: 130,753 shares; 2022Q3: 130,136 shares 130,136$165K0.05%-617
ATHENEX INCATHENEX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: not reported; 2022Q3: 526,651 shares 526,651$142K0.05%new

Sold out in Q3 2022

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
BSXBOSTON SCIENTIFIC CORP418,165$15.6Mshares
SPYSTATE STR SPDR S&P 500 ETF T25,900$9.77Mput
XBISPDR SERIES TRUST126,000$9.36Mcall
HOLXHOLOGIC INC127,656$8.85Mshares
SEAGEN INCSEAGEN INC32,871$5.82Mshares
CNCCENTENE CORP DEL68,305$5.78Mshares
SIBNSI BONE INC430,159$5.68Mshares
QQQINVESCO QQQ TR13,300$3.73Mput
NBIXNEUROCRINE BIOSCIENCES INC27,992$2.73Mshares
GLOBAL BLOOD THERAPEUTICS U…GLOBAL BLOOD THERAPEUTICS USD81,007$2.59Mshares
INCYINCYTE CORP31,211$2.37Mshares
XBISPDR SERIES TRUST31,349$2.33Mshares
DXCMDEXCOM INC26,046$1.94Mshares
FATEFATE THERAPEUTICS INC71,640$1.77Mshares
CORCENCORA INC11,515$1.63Mshares
ACHCACADIA HEALTHCARE COMPANY IN16,189$1.09Mshares
ZBHZIMMER BIOMET HOLDINGS INC9,949$1.04Mshares
HORIZON THERAPEUTICS PLCHORIZON THERAPEUTICS PLC8,454$674Kshares
AXSMAXSOME THERAPEUTICS INC.15,246$584Kshares
ADCTADC THERAPEUTICS SA58,967$469Kshares
PRAXIS PRECISION MEDICINES IPRAXIS PRECISION MEDICINES I79,097$194Kshares
IMUXIMMUNIC INC30,591$106Kshares

How Q3 2022 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001633055-22-000007 base2022-11-14acceptance time not in the bulk data set